Literature DB >> 15633223

Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome.

Jun-Ho La1, Tae-Wan Kim, Tae-Sik Sung, Hyn-Ju Kim, Jeom-Yong Kim, Il-Suk Yang.   

Abstract

AIM: Irritable bowel syndrome (IBS) is a functional bowel disorder. Its major symptom is bowel dysmotility, yet the mechanism of the symptom is poorly understood. Since the neurokinin-1 receptor (NK1R)-mediated signaling in the gut is important in the control of normal bowel motor function, we aimed to investigate whether the NK1R-mediated bowel motor function was altered in IBS, using a rat IBS model that was previously reported to show colonic dysmotility in response to restraint stress.
METHODS: IBS symptoms were produced in male Sprague-Dawley rats by inducing colitis with acetic acid. Rats were left to recover from colitis for 6 d, and used for experiments 7 d post-induction of colitis. Motor activities of distal colon were recorded in vitro.
RESULTS: The contractile sensitivity of isolated colon to a NK1R agonist (Sar9,Met(O2)11)-substance P (1-30 nmol/L) was higher in IBS rats than that in normal rats. After the enteric neurotransmission was blocked by tetrodotoxin (TTX, 1 micromol/L), the contractile sensitivity to the NK1R agonist was increased in normal colon but not in IBS rat colon. The NK1R agonist-induced contraction was not different between the two groups when the agonist was challenged to the TTX-treated colon or the isolated colonic myocytes. A nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME, 100 micromol/L) augmented the NK1R agonist-induced contraction only in normal rat colon.
CONCLUSION: These results suggest that the NK1R-meidated colonic motor response is increased in IBS rats, due to the decrease in the nitrergic inhibitory neural component.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633223      PMCID: PMC4205409          DOI: 10.3748/wjg.v11.i2.237

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Damage to the enteric nervous system in experimental colitis.

Authors:  S Sanovic; D P Lamb; M G Blennerhassett
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Involvement of nitric oxide in the substance P-induced inhibition of intestinal peristalsis.

Authors:  P Holzer
Journal:  Neuroreport       Date:  1997-09-08       Impact factor: 1.837

Review 3.  Tachykinins in the gut. Part I. Expression, release and motor function.

Authors:  P Holzer; U Holzer-Petsche
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  Temporal distribution of neuronal and inducible nitric oxide synthase and nitrotyrosine during colitis in rats.

Authors:  M Miampamba; K A Sharkey
Journal:  Neurogastroenterol Motil       Date:  1999-06       Impact factor: 3.598

5.  Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".

Authors:  G Isenberg; U Klockner
Journal:  Pflugers Arch       Date:  1982-10       Impact factor: 3.657

6.  Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis.

Authors:  Jun-Ho La; Tae-Wan Kim; Tae-Sik Sung; Jeoung-Woo Kang; Hyun-Ju Kim; Il-Suk Yang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Human colonic motility. A comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome.

Authors:  N A Chaudhary; S C Truelove
Journal:  Gastroenterology       Date:  1968-04       Impact factor: 22.682

8.  RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in rat.

Authors:  K Ikeda; K Miyata; A Orita; H Kubota; T Yamada; K Tomioka
Journal:  Neurosci Lett       Date:  1995-09-29       Impact factor: 3.046

Review 9.  Neuropathophysiology of irritable bowel syndrome.

Authors:  Jackie D Wood
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

10.  Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles.

Authors:  U Scheurer; E Drack; F Halter
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

View more
  7 in total

1.  Brain-Derived Neurotrophic Factor Contributes to Colonic Hypermotility in a Chronic Stress Rat Model.

Authors:  Xiaojing Quan; Hesheng Luo; Han Fan; Qincai Tang; Wei Chen; Ning Cui; Guang Yu; Hong Xia
Journal:  Dig Dis Sci       Date:  2015-05-12       Impact factor: 3.199

2.  Antinociceptive effect of berberine on visceral hypersensitivity in rats.

Authors:  Qing-Lin Tang; Min-Ling Lai; Yuan-Fu Zhong; Ai-Min Wang; Jun-Kai Su; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

3.  Reduction of gastrointestinal motility by unilateral thyroparathyroidectomy plus subdiaphragmatic vagotomy in rats.

Authors:  Jun Ho Lee; Oh Deog Kwon; Seon Ho Ahn; Keun Han Choi; Ji Hye Park; Seoul Lee; Bong Kyu Choi; Kyu Yong Jung
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

4.  Characteristics of deslanoside-induced modulation on jejunal contractility.

Authors:  Da-Peng Chen; Yong-Jian Xiong; Ze-Yao Tang; Qi-Ying Yao; Dong-Mei Ye; Sha-Sha Liu; Yuan Lin
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

5.  Visceral Hypersensitivity and Altered Colonic Motility in Type 2 Diabetic Rat.

Authors:  Tae Sik Sung; Jun-Ho La; Tong Mook Kang; Tae Wan Kim; Il-Suk Yang
Journal:  J Neurogastroenterol Motil       Date:  2015-10-01       Impact factor: 4.924

6.  Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats.

Authors:  Changchun Yu; Yongjian Xiong; Dapeng Chen; Yanli Li; Bin Xu; Yuan Lin; Zeyao Tang; Chunling Jiang; Li Wang
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

7.  Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.

Authors:  Tijen Kaya Temiz; Omer Demir; Fatma Simsek; Yusuf Cem Kaplan; Selen Bahceci; Barıs Karadas; Aslı Celik; Gokhan Koyluoglu
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.